Literature DB >> 33715034

Abdominal obesity, and not general obesity, is associated with a lower 123I MIBG heart-to-mediastinum ratio in heart failure patients with preserved ejection fraction.

Akihiro Sunaga1, Shungo Hikoso2, Takahisa Yamada3, Yoshio Yasumura4, Masaaki Uematsu5, Haruhiko Abe5, Yusuke Nakagawa6, Yoshiharu Higuchi7, Hisakazu Fuji8, Toshiaki Mano9, Hiroyuki Kurakami10, Tomomi Yamada10, Tetsuhisa Kitamura11, Taiki Sato1, Bolrathanak Oeun1, Hirota Kida1, Takayuki Kojima1, Yohei Sotomi1, Tomoharu Dohi1, Katsuki Okada1, Shinichiro Suna1, Hiroya Mizuno1, Daisaku Nakatani1, Yasushi Sakata1.   

Abstract

BACKGROUND: The relationship between general obesity or abdominal obesity (abdominal circumference of ≥85 cm in men and ≥ 90 cm in women) and the heart-to-mediastinum ratio (HMR), a measure of cardiac sympathetic innervation, on cardiac iodine-123-metaiodobenzylguanidine scintigraphy (MIBG) in patients with heart failure with preserved ejection fraction (HFpEF) has not been clarified.
METHODS: A total of 239 HFpEF patients with both MIBG and abdominal circumference data were examined. We divided these patients into those with abdominal obesity and those without it. In the cardiac MIBG study, early phase image was acquired 15-20 min after injection, and late phase image was acquired 3 h after the early phase. A HMR obtained from a low-energy type collimator was converted to that obtained by a medium-energy type collimator.
RESULTS: Early and late HMRs were significantly lower in those with abdominal obesity, although washout rates were not significantly different. The incidence of patients with early and late HMRs <2.2 was significantly higher in those with abdominal obesity. Multivariate linear regression analysis revealed that abdominal obesity was independently associated with early HMR (standardized β = -0.253, P = 0.003) and late HMR (standardized β = -0.222, P = 0.010). Multivariate logistic regression analysis revealed that abdominal obesity was independently associated with early (odds ratio [OR] [95% confidence interval {CI}] = 4.25 [2.13, 8.47], P < 0.001) and late HMR < 2.2 (OR [95% CI] = 2.06 [1.11, 3.83], P = 0.022). Elevated BMI was not significantly associated with low early and late HMR. The presence of abdominal obesity was significantly associated with low early and late HMR even in patients without elevated BMI values.
CONCLUSION: Abdominal obesity, but not general obesity, in HFpEF patients was independently associated with low HMR, suggesting that visceral fat may contribute to decreased cardiac sympathetic activity in patients with HFpEF. TRIAL REGISTRATION: UMIN000021831.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Abdominal circumference; Abdominal obesity; Heart failure; Heart to mediastinum ratio; Iodine-123-metaiodobenzylguanidine scintigraphy; Preserved ejection fraction

Mesh:

Substances:

Year:  2021        PMID: 33715034     DOI: 10.1007/s00259-021-05280-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  2 in total

1.  Impact of obesity and acquisition protocol on (123)I-metaiodobenzylguanidine indexes of cardiac sympathetic innervation.

Authors:  Teresa Pellegrino; Valentina Piscopo; Antonio Boemio; Barbara Russo; Gianluca De Matteis; Sara Pellegrino; Sara Maria Delle Acque Giorgio; Manuela Amato; Mario Petretta; Alberto Cuocolo
Journal:  Quant Imaging Med Surg       Date:  2015-12

2.  Myocardial imaging in man with I-123 meta-iodobenzylguanidine.

Authors:  R C Kline; D P Swanson; D M Wieland; J H Thrall; M D Gross; B Pitt; W H Beierwaltes
Journal:  J Nucl Med       Date:  1981-02       Impact factor: 10.057

  2 in total
  2 in total

Review 1.  123I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation.

Authors:  Paola Gargiulo; Wanda Acampa; Gaetano Asile; Vincenza Abbate; Ermanno Nardi; Federica Marzano; Roberta Assante; Carmela Nappi; Antonio Luca Maria Parlati; Christian Basile; Santo Dellegrottaglie; Stefania Paolillo; Alberto Cuocolo; Pasquale Perrone-Filardi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-08       Impact factor: 10.057

Review 2.  Dosing Therapeutic Radiopharmaceuticals in Obese Patients.

Authors:  Merel van Nuland; Tessa F Ververs; Marnix G E H Lam
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.